Co. Works to Strengthen Itself After Merger Ended
Source: Scott Fortune
August 3, 2023 (Investorideas.com Newswire) Its efforts include restructuring debt and divesting assets, noted a ROTH Capital Partners report.
Columbia Care Inc. (CCHW:CSE; CCHWF:OTCMKTS) and Cresco Labs called off their merger announced in March 2022, reported ROTH Capital Partners analyst Scott Fortune in a July 31 research note. Since Columbia Care has taken steps to "accelerate operational efficiencies and cash flow to better position the standalone business."
Fortune added that "execution on the balance sheet side along with right-sizing should still drive the upside of shares, currently trading below 0.5 times 2023 enterprise value:sales. We look for additional execution to improve margins while key new adult-use states drive topline growth to offset divestitures."
Significant Gain for Investors
ROTH reiterated its Buy rating and its US$1 per share target price on the U.S.-based seller of medical and recreational cannabis, currently trading at about US$0.42 per share. From this price, the return to the target reflects a material return, of 138%, for investors.
Steps Taken To Rebound
Columbia Care restructured its debt of about US$330 million ($330M), of which US$44M is due in less than a year's time. Specifically, it converted its 13% notes totaling US$38.2M due in 2024 to 9.5% notes due in 2026. Also, it obtained commitments from several of its top holders.
"We view this as a key positive, as this reduces near-term obligations while lowering cash interest costs for the next three years," Fortune wrote.
Lowering Head Count
Also, the New York-headquartered firm reduced its number of employees by 52, on the gLeaf side, for an estimated increase to 2023 EBITDA of about US$950,000.
Selling Certain Assets
Another of Columbia Care's strategies is asset divestiture. The cannabis firm just closed on the sale of its facility in downtown Los Angeles, California, for about US$9M gross. Of that, it should net US$3M after taxes and the mortgage are paid.
"Proceeds will be used to reduce overall debt, and the sale will reduce annual operating costs by about US$8.5M in California, according to management," reported Fortune.
The company has begun the process of divesting its assets in Missouri, too.
Fortune highlighted that Columbia Care's 85 dispensaries in 16 states will continue expanding revenue and margins and ultimately "lead to an easier path to managing future debt."
Plus, the company has additional dispensaries slated to come online in New Jersey, Maryland, and Virginia, and, the analyst added, "the right sizing of assets to prioritize these states will help drive margin growth through 2024."
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Sign up for free stock news alerts at Investorideas.com